Influence of co-infection complicated with human papillomavirus on cervical intraepithelial neoplasia development in patients with atypical squamous cells of undetermined significance

Journal of Infection and Chemotherapy

Volumn 23, Issue 12, 2017, Pages 814-819

  Kiseki, Hisami ^a   Tsukahara, Yutaka ^a   Tajima, Natsumi ^a   Tanaka, Ayako ^a   Horimoto, Aya ^a   Hashimura, Naohiko ^a  

^a Kohsei Chuo General Hospital   (Japan)

Author keywords

Atypical squamous cells of undetermined significance; Cervical intraepithelial neoplasia; Human papillomavirus; Vaginal infection

Indexed keywords

ADULT; AGE; ARTICLE; BACTERIAL INFECTION; CANCER GRADING; CANCER PATIENT; CANCER PROGNOSIS; CANDIDA; CANDIDIASIS; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL EVALUATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CORYNEBACTERIUM; CORYNEBACTERIUM INFECTION; DISEASE ASSOCIATION; ENTEROCOCCAL INFECTION; ENTEROCOCCUS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; GARDNERELLA INFECTION; GARDNERELLA VAGINALIS; GENITAL HERPES; GONORRHEA; GROUP B STREPTOCOCCAL INFECTION; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; INFECTION RATE; MAJOR CLINICAL STUDY; MIXED INFECTION; NEISSERIA GONORRHOEAE; PAPILLOMAVIRUS INFECTION; PUNCH BIOPSY; RETROSPECTIVE STUDY; SEXUALLY TRANSMITTED DISEASE; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS AGALACTIAE; TUMOR BIOPSY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; VAGINITIS; VIRUS CARCINOGENESIS; VIRUS PATHOGENESIS; WART VIRUS; COMPLICATION; GENETICS; MICROBIOLOGY; PAPILLOMAVIRIDAE; STATISTICAL MODEL; UTERINE CERVIX TUMOR; VAGINA DISEASE; VIROLOGY;

ADULT; ATYPICAL SQUAMOUS CELLS OF THE CERVIX; CERVICAL INTRAEPITHELIAL NEOPLASIA; COINFECTION; FEMALE; HUMANS; LOGISTIC MODELS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS; VAGINAL DISEASES;

EID: 85028823079     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1016/j.jiac.2017.08.008     Document Type: Article

References (38)

1. Walboomers, J.M., Jacobs, M.V., Manos, M.M., Bosch, F.X., Kummer, J.A., Shah, K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 (1999), 12–19.
2. Future II Study Group, Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 356 (2007), 1915–1927.
3. Bosch, F.X., de Sanjose, S., Chapter 1: human papillomavirus and cervical cancer–burden and assessment of causality. J Natl Cancer Inst Monogr 31 (2003), 3–13.
4. Solomon, D., Davey, D., Kurman, R., Moriarty, A., O'Connor, D., Prey, M., et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 287 (2002), 2114–2119.
5. Guideline for gynecological practice in Japan 2017, Guideline for gynecological practice in Japan 2017, 2017, Japan society of obstetrics and gynecology, Tokyo, 42–46.
6. Jordan, J., Arbyn, M., Martin-Hirsch, P., Schenck, U., Baldauf, J.J., Da Silva, D., et al. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1. Cytopathology 19 (2008), 342–354.
7. Committee on Practice Bulletins gynecology, Practice bulletin no. 168: cervical cancer screening and prevention. Obstet Gynecol 128 (2016), e111–e130.
8. Wright, T.C. Jr., Massad, L.S., Dunton, C.J., Spitzer, M., Wilkinson, E.J., Solomon, D., 2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 197 (2007), 346–355.
9. Stoler, M.H., Wright, T.C. Jr., Sharma, A., Apple, R., Gutekunst, K., Wright, T.L., ATHENA (Addressing THE Need for Advanced HPV Diagnostics) HPV Study Group. High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study. Am J Clin Pathol 135 (2011), 468–475.
10. zur Hausen, H., Human genital cancer: synergism between two virus infections or synergism between a virus infection and initiating events?. Lancet 2 (1982), 1370–1372.
11. Ghosh, I., Mandal, R., Kundu, P., Biswas, J., Association of genital infections other than human papillomavirus with pre-invasive and invasive cervical neoplasia. J Clin Diagn Res 10 (2016), XE01–XE06.
12. Schneider, A., Pathogenesis of genital HPV infection. Genitourin Med 69 (1993), 165–173.
13. Zhu, H., Shen, Z., Luo, H., Zhang, W., Zhu, X., Chlamydia Trachomatis infection-associated risk of cervical cancer: a meta-analysis. Medicine (Baltimore), 95, 2016, e3077.
14. Knowlton, A.E., Brown, H.M., Richards, T.S., Andreolas, L.A., Patel, R.K., Grieshaber, S.S., Chlamydia trachomatis infection causes mitotic spindle pole defects independently from its effects on centrosome amplification. Traffic 12 (2011), 854–866.
15. Johnson, K.A., Tan, M., Sutterlin, C., Centrosome abnormalities during a Chlamydia trachomatis infection are caused by dysregulation of the normal duplication pathway. Cell Microbiol 11 (2009), 1064–1073.
16. Grieshaber, S.S., Grieshaber, N.A., Miller, N., Hackstadt, T., Chlamydia trachomatis causes centrosomal defects resulting in chromosomal segregation abnormalities. Traffic 7 (2006), 940–949.
17. Einstein, M.H., Garcia, F.A., Mitchell, A.L., Day, S.P., Age-stratified performance of the Cervista HPV 16/18 genotyping test in women with ASC-US cytology. Cancer Epidemiol Biomarkers Prev 20 (2011), 1185–1189.
18. Guo, M., Gong, Y., Wang, J., Dawlett, M., Patel, S., Liu, P., et al. The role of human papillomavirus type 16/18 genotyping in predicting high-grade cervical/vaginal intraepithelial neoplasm in women with mildly abnormal Papanicolaou results. Cancer Cytopathol 121 (2013), 79–85.
19. Hall, J., Kendall, B., High risk human papillomavirus DNA detection in pap tests with both atypical squamous cells of undetermined significance and Candida. Acta Cytol 53 (2009), 150–152.
20. Menon, S., Broeck, D.V., Rossi, R., Ogbe, E., Harmon, S., Mabeya, H., Associations between vaginal infections and potential high-risk and high-risk human papillomavirus genotypes in female sex workers in western Kenya. Clin Ther 38 (2016), 2567–2577.
21. Rodriguez-Cerdeira, C., Sanchez-Blanco, E., Alba, A., Evaluation of association between vaginal infections and high-risk human papillomavirus types in female sex workers in Spain. ISRN Obstet Gynecol, 2012, 2012, 240190.
22. Voog, E., Bolmstedt, A., Olofsson, S., Ryd, W., Lowhagen, G.B., Human papilloma virus infection among women attending an STD clinic correlated to reason for attending, presence of clinical signs, concomitant infections and abnormal cytology. Acta Derm Venereol 75 (1995), 75–78.
23. McNicol, P., Paraskevas, M., Guijon, F., Variability of polymerase chain reaction-based detection of human papillomavirus DNA is associated with the composition of vaginal microbial flora. J Med Virol 43 (1994), 194–200.
24. Samoff, E., Koumans, E.H., Markowitz, L.E., Sternberg, M., Sawyer, M.K., Swan, D., et al. Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am J Epidemiol 162 (2005), 668–675.
25. de Abreu, A.L., Malaguti, N., Souza, R.P., Uchimura, N.S., Ferreira, E.C., Pereira, M.W., et al. Association of human papillomavirus, Neisseria gonorrhoeae and Chlamydia trachomatis co-infections on the risk of high-grade squamous intraepithelial cervical lesion. Am J Cancer Res 6 (2016), 1371–1383.
26. Mitra, A., MacIntyre, D.A., Marchesi, J.R., Lee, Y.S., Bennett, P.R., Kyrgiou, M., The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next?. Microbiome, 4, 2016, 58.
27. Audirac-Chalifour, A., Torres-Poveda, K., Bahena-Roman, M., Tellez-Sosa, J., Martinez-Barnetche, J., Cortina-Ceballos, B., et al. Cervical microbiome and cytokine profile at various stages of cervical cancer: a pilot study. PLoS One, 11, 2016, e0153274.
28. Lee, J.E., Lee, S., Lee, H., Song, Y.M., Lee, K., Han, M.J., et al. Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort. PLoS One, 8, 2013, e63514.
29. Janulaitiene, M., Paliulyte, V., Grinceviciene, S., Zakareviciene, J., Vladisauskiene, A., Marcinkute, A., et al. Prevalence and distribution of Gardnerella vaginalis subgroups in women with and without bacterial vaginosis. BMC Infect Dis, 17, 2017, 394.
30. Patras, K.A., Wescombe, P.A., Rosler, B., Hale, J.D., Tagg, J.R., Doran, K.S., Streptococcus salivarius K12 limits group B Streptococcus vaginal colonization. Infect Immun 83 (2015), 3438–3444.
31. Landwehr-Kenzel, S., Henneke, P., Interaction of Streptococcus agalactiae and cellular innate immunity in colonization and disease. Front Immunol, 5, 2014, 519.
32. Tansarli, G.S., Skalidis, T., Legakis, N.J., Falagas, M.E., Abnormal vaginal flora in symptomatic non-pregnant and pregnant women in a Greek hospital: a prospective study. Eur J Clin Microbiol Infect Dis 36 (2017), 227–232.
33. Rosenstein, I.J., Morgan, D.J., Sheehan, M., Lamont, R.F., Taylor-Robinson, D., Bacterial vaginosis in pregnancy: distribution of bacterial species in different gram-stain categories of the vaginal flora. J Med Microbiol 45 (1996), 120–126.
34. Borgdorff, H., van der Veer, C., van Houdt, R., Alberts, C.J., de Vries, H.J., Bruisten, S.M., et al. The association between ethnicity and vaginal microbiota composition in Amsterdam, The Netherlands. PLoS One, 12, 2017, e0181135.
35. Numanovic, F., Smajlovic, J., Gegic, M., Delibegovic, Z., Bektas, S., Halilovic, E., et al. Presence and resistance of Streptococcus agalactiae in vaginal specimens of pregnant and adult non-pregnant women and association with other aerobic bacteria. Med Glas (Zenica) 14 (2017), 98–105.
36. Castro, J., Machado, D., Cerca, N., Escherichia coli and Enterococcus faecalis are able to incorporate and enhance a pre-formed Gardnerella vaginalis biofilm. Pathog Dis, 74, 2016 pii: ftw007.
37. Chumduri, C., Gurumurthy, R.K., Zadora, P.K., Mi, Y., Meyer, T.F., Chlamydia infection promotes host DNA damage and proliferation but impairs the DNA damage response. Cell Host Microbe 13 (2013), 746–758.
38. Kojima, S., Kawana, K., Fujii, T., Yokoyama, T., Miura, S., Tomio, K., et al. Characterization of gut-derived intraepithelial lymphocyte (IEL) residing in human papillomavirus (HPV)-infected intraepithelial neoplastic lesions. Am J Reprod Immunol 66 (2011), 435–443.